As of 2025-07-15, the Relative Valuation of Alliance Pharma PLC (APH.L) is (25.50) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 64.70 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -139.4%.
The range of the Relative Valuation is (23.21) - (27.93) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 14.3x | 12.0x |
| Forward P/E multiples | 11.9x - 16.3x | 14.2x |
| Fair Price | (23.21) - (27.93) | (25.50) |
| Upside | -135.9% - -143.2% | -139.4% |
| Date | P/E |
| 2025-05-14 | -33.17 |
| 2025-05-13 | -33.17 |
| 2025-05-12 | -33.17 |
| 2025-05-09 | -33.07 |
| 2025-05-08 | -33.12 |
| 2025-05-07 | -33.12 |
| 2025-05-06 | -33.12 |
| 2025-05-02 | -33.12 |
| 2025-05-01 | -33.07 |
| 2025-04-30 | -33.12 |
| 2025-04-29 | -33.07 |
| 2025-04-28 | -33.07 |
| 2025-04-25 | -33.12 |
| 2025-04-24 | -33.02 |
| 2025-04-23 | -32.97 |
| 2025-04-22 | -32.97 |
| 2025-04-17 | -32.92 |